1'757 companies found
Sulfiscon SA
Pully · Since 2017
The core activity of SULFISCON is the development of new therapies for the treatment of calcification disorders, particularly osteoarthritis and other musculoskeletal diseases. The company focuses on the research and development of drugs based on the mechanisms of crystal-induced musculoskeletal diseases.
SunRegen Healthcare AG
Reinach Bl · Since 2017
The core activity of SunRegen Healthcare AG is the development of medications for the treatment of neurodegenerative diseases, particularly retinal neurodegenerations such as Retinitis Pigmentosa, age-related macular degeneration and glaucoma, as well as central nervous system neurodegenerations such as Alzheimer's, Huntington's, Parkinson's and ALS. The company focuses on the development of oral therapeutics that inhibit neuronal apoptosis and exhibit neuroprotective effects.
suterscience GmbH
Basel · Since 2007
Swiscomed AG
Münchwilen Ag · Since 2007
Swiss-Canna Group AG
Freienbach · Since 2012
The core activity of Swiss-Canna Group AG is the development and manufacture of CBD-based, non-prescription health products based on scientific principles, combining natural principles and state-of-the-art technology. The company focuses on creating premium natural products that offer the highest product quality, maximum effectiveness and consistent customer orientation.
SWISSderm AG
Lucerne · Since 2007
Swissmountainpharma AG
Castaneda · Since 2018
Swiss Rockets Enterprise AG
Basel · Since 2021
The core activity of SWR Trading AG is the distribution of medical products and personal protective equipment, in particular nitrile gloves, face masks and protective gowns.
Sympatch Sàrl
Meyrin · Since 2024
Sympatch Sàrl sells transdermal CBD patches intended to relieve menstrual and premenstrual discomfort such as cramps, lower‑back pain and bloating. The patch contains 20 mg of CBD isolate (0% THC), is dermatologically tested and the company states the CBD is cultivated in Switzerland.
Synthena AG
Bern · Since 2012
TACHRIS AG
Wollerau · Since 2008
Tandem Therapeutics AG
Schlieren · Since 2023
The core activity of Tandem Therapeutics AG is the development of transformative medicines that focus on the extracellular matrix, particularly for the treatment of fibrotic diseases and fibrotic cancer forms. The company uses Matrix-Targeting-Peptides (MTP) that conditionally target disease-associated matrix changes to overcome the extracellular matrix barrier and enable new therapeutic approaches.
Tenpoint Therapeutics GmbH
Basel · Since 2024
The core activity of Tenpoint Therapeutics, Ltd. is the development of innovative therapies for eye diseases, particularly for the treatment of age-related eye problems such as presbyopia, cataracts, and geographic atrophy. The company focuses on developing paradigmatic treatments for the largest ophthalmological indications with the greatest unmet need and global market potential.
Terra Rhenus pharmaceutics AG
Rheineck · Since 2020
Topotarget Switzerland SA
Geneva · Since 1999
Travere Therapeutics Switzerland GmbH
Rapperswil Sg · Since 2021
Travere Therapeutics develops and distributes innovative therapies for rare diseases, particularly IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS), Classical Homocystinuria (HCU), and Cystinuria.
UPSA Switzerland AG
Zug · Since 2019
The core activity of UPSA Switzerland AG is the development, manufacture and marketing of medicines, medical devices and dietary supplements.
VASPERIS SA
Geneva · Since 2010
O'TENTIKA is a cosmetics company specializing in the manufacture and distribution of skin and facial care products. The company's core activity encompasses the development, production, and sale of premium skin care products, particularly in the field of skin refinement and care.
Vaxcyte Switzerland GmbH
Baar · Since 2023
VectivBio AG
Basel · Since 2019
How the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register